Our findings also demonstrate that the pro-apoptotic potential of BID is negatively regulated by N-terminal cysteines, indicating that these cysteines could be targeted by covalent inhibitors for the induction of apoptosis and potential cancer therapeutics. Here, BID is linked to cancer.